M&A | Partnerships

LifeHealthcare will sell STIMULAN and genex calcium matrices for surgical use in musculoskeletal infections, trauma, spine and foot/ankle.

The technology has shown encouraging early results for regrowth of long bone defects in patients who have lost more than six centimeters of bone.

The companies have collaborated since 2015 to develop collagen-based bone graft products used in orthopedic and dental applications.

DUROLANE single-injection hyaluronic acid treats pain associated with osteoarthritis in the knee, hip and small joints.

Seikagaku and Eisai will co-develop and market knee osteoarthritis treatment SI-613 in China.

Acumed entered into an agreement to distribute Vivorte's orthobiologic portfolio on an exclusive basis.

Biologics4Life completed an exclusive licensing agreement to secure rights to initial technologies for bone tissue regeneration.

Anika Therapeutics signed agreements to acquire Parcus Medical and Arthrosurface within 1Q20.

Advanced Medical Solutions acquired Biomatlante, developer, and manufacturer of orthobiologic products with application in joint reconstruction, spine, trauma, and sports medicine procedures.

Molecular Matrix will enter into a strategic alliance with Philosys Healthcare to expand availability of bone graft substitute technology in the Asian market.